Raiffeisen Bank International’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.41M Buy
32,876
+1,876
+6% +$167K 0.04% 233
2026
Q1
$2.17M Buy
31,000
+12,634
+69% +$973K 0.03% 275
2025
Q4
$1.47M Sell
18,366
-891
-5% -$70.2K 0.02% 287
2025
Q3
$1.46M Buy
19,257
+9,825
+104% +$673K 0.02% 276
2025
Q2
$626K Sell
9,432
-339
-3% -$22.2K 0.01% 345
2025
Q1
$656K Buy
9,771
+1,191
+14% +$71.3K 0.01% 327
2024
Q4
$377K Buy
+8,580
New +$481K 0.01% 386

Other funds holding CVS

Raiffeisen Bank International's CVS Position: Q2 2026 in Review

Raiffeisen Bank International increased its CVS Health (CVS) stake by 6.1% in Q2 2026, buying an estimated $167K and bringing the position to 32,876 shares worth $3.41M. The position accounts for 0.04% of the portfolio, ranked #233.

Raiffeisen Bank International first reported a position in CVS in Q4 2024 and has held it in 7 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Raiffeisen Bank International held 32,876 shares of CVS Health worth $3.41M as of Q2 2026.
  • Raiffeisen Bank International bought 1,876 CVS Health shares in Q2 2026, an estimated $167K.
  • CVS Health made up 0.04% of Raiffeisen Bank International's portfolio in Q2 2026, its #233 holding.
  • Raiffeisen Bank International first reported a position in CVS Health in Q4 2024 and has held it in 7 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.